CARMEN MURILLO: Open Payments
NPI 1982149159 · WILLOWBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,575 in 123 payments from 21 companies in 2025. Trend: 2023 $1,829 · 2024 $1,396 · 2025 $4,575
Food & beverage: $3,734Travel & lodging: $763Education: $78
| Company | Payments | Amount |
|---|---|---|
| UCB SA | 8 | $1,063 |
| Amgen Inc. | 19 | $822 |
| ABBVIE INC. | 27 | $765 |
| Janssen Biotech, Inc. | 10 | $340 |
| GlaxoSmithKline, LLC. | 10 | $293 |
| UCB, Inc. | 12 | $181 |
| GENZYME CORPORATION | 3 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $135 |
| Novo Nordisk Inc | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
Products named: EVENITY, TREMFYA, RINVOQ, SKYRIZI, BENLYSTA, OTEZLA, KRYSTEXXA, KEVZARA.
Industry payments across IL — which companies pay providers there.
